Table 1.

Correlation between ANLN expression and clinicopathological characteristics in PCa

Characteristics	Low expression of ANLN	High expression of ANLN	P value
n	250	251
Pathologic T stage, n (%)			< 0.001
T2	121 (24.5%)	68 (13.8%)
T3	122 (24.7%)	172 (34.8%)
T4	3 (0.6%)	8 (1.6%)
Pathologic N stage, n (%)			0.002
N0	174 (40.7%)	174 (40.7%)
N1	25 (5.8%)	55 (12.9%)
Gleason score, n (%)			< 0.001
6	34 (6.8%)	12 (2.4%)
7	149 (29.7%)	99 (19.8%)
8	28 (5.6%)	37 (7.4%)
9&10	39 (7.8%)	103 (20.6%)
PSA (ng/ml), n (%)			0.026
< 4	216 (48.6%)	201 (45.3%)
≥ 4	8 (1.8%)	19 (4.3%)
PFI event, n (%)			< 0.001
No	220 (43.9%)	187 (37.3%)
Yes	30 (6%)	64 (12.8%)

Note: The ANLN low and high-expression groups were divided by the median ANLN expression value.